C12N 2501/40
Regulators of development
C12N2501/40 (Regulators of development) appears on 1,317 US grants and 2,804 published applications in this corpus.
Search patents in C12N- Granted patents
- 1,317
- Published applications
- 2,804
- Assignees
- 898
- Inventors
- 4,321
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 4 | 0 |
| 1999 | 1 | 0 |
| 2000 | 4 | 0 |
| 2001 | 4 | 6 |
| 2002 | 2 | 12 |
| 2003 | 9 | 21 |
| 2004 | 2 | 38 |
| 2005 | 5 | 28 |
| 2006 | 7 | 45 |
| 2007 | 6 | 44 |
| 2008 | 9 | 36 |
| 2009 | 25 | 72 |
| 2010 | 26 | 91 |
| 2011 | 24 | 77 |
| 2012 | 28 | 76 |
| 2013 | 36 | 95 |
| 2014 | 61 | 100 |
| 2015 | 70 | 137 |
| 2016 | 71 | 170 |
| 2017 | 92 | 137 |
| 2018 | 98 | 157 |
| 2019 | 103 | 161 |
| 2020 | 97 | 181 |
| 2021 | 84 | 179 |
| 2022 | 78 | 200 |
| 2023 | 79 | 192 |
| 2024 | 109 | 198 |
| 2025 | 103 | 199 |
| 2026 | 80 | 152 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Haematopoietic stem/progenitor cells29 Sep 2026US 12,747,424 B2Murdoch Childrens Research Institute
- Compositions and methods for providing hematopoietic function without HLA matching22 Sep 2026US 12,741,001 B2Fred Hutchinson Cancer Center
- Method for obtaining healthy intestinal organoids22 Sep 2026US 12,741,061 B2Precision Cancer Technologies Inc.
- Fixed ratio ex vivo activated mixed lymphocyte products for use in the treatment of cancer22 Sep 2026US 12,742,153 B2Children's National Medical Center
- Pluripotent stem cell-derived heart organoid22 Sep 2026US 12,742,157 B2Board of Trustees of Michigan State University
- Nk cell compositions and preparations for immunotherapy and methods for their production8 Oct 2026US 2026/0308226 A1Deverra Therpaeutics Inc.
- Protocol for maturation of 3D engineered heart tissue8 Oct 2026US 2026/0308527 A1
- Micropattern-assisted generation of tissue8 Oct 2026US 2026/0308533 A1
- Cryopreserved endocrine cells that express chromogranin a1 Oct 2026US 2026/0294981 A1ViaCyte, Inc.
- T cell progenitor production method1 Oct 2026US 2026/0297522 A1Kyoto University
Most cited
By later US patents
- RNA containing modified nucleosides and methods of use thereof353US 8,278,036 B2The Trustees of the University of Pennsylvania · 2012
- RNA containing modified nucleosides and methods of use thereof230US 8,691,966 B2The Trustees of the University of Pennsylvania · 2014
- RNA containing modified nucleosides and methods of use thereof222US 8,748,089 B2The Trustees of the University of Pennsylvania · 2014
- Definitive endoderm221US 7,510,876 B2Cythera, Inc. · 2009
- Targeted RNA degradation using nuclear antisense RNA207US 5,908,779 AUniversity of Connecticut · 1999